Market Cap 6.86B
Revenue (ttm) 2.53B
Net Income (ttm) 265.24M
EPS (ttm) N/A
PE Ratio 24.83
Forward PE 22.98
Profit Margin 10.48%
Debt to Equity Ratio 0.17
Volume 115,100
Avg Vol 188,874
Day's Range N/A - N/A
Shares Out 13.07M
Stochastic %K 24%
Beta 0.51
Analysts Sell
Price Target $547.40

Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, doctors, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates through two segments: VITAS and Roto-Rooter segments. The company offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractor...

Industry: Medical Care Facilities
Sector: Healthcare
Phone: 513 762 6690
Address:
2600 First Financial Center, 255 East Fifth Street Suite 2600, Cincinnati, United States
STRelativeStrength
STRelativeStrength Aug. 10 at 2:36 PM
$CHE undiscovered breakout with 299 watchers
1 · Reply
MichaelKost
MichaelKost Aug. 8 at 6:41 PM
$CHE I'll give it another look tomorrow
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Jul. 28 at 8:36 PM
$CHE Q2 '26 Earnings Results & Recap • Reported GAAP EPS of $5.14 up 42.78% YoY • Reported revenue of $673.25M up 8.80% YoY • Chemed Corporation raised its full-year 2026 earnings per diluted share guidance to a range of $25.00 to $25.75, representing a 17.8% increase from 2025 adjusted earnings per diluted share.
0 · Reply
onlythebestcompanies
onlythebestcompanies Jul. 21 at 12:54 PM
$CHE $600 soon.
0 · Reply
onlythebestcompanies
onlythebestcompanies Jul. 17 at 12:52 PM
$CHE $600 soon.
0 · Reply
IN0V8
IN0V8 Jul. 9 at 5:32 PM
$CHE Opportunity BofA Global Research raises price objective to $510.00 from $450.00
0 · Reply
onlythebestcompanies
onlythebestcompanies Jul. 6 at 7:11 AM
$CHE $600 soon.
0 · Reply
leochoi834
leochoi834 Jul. 3 at 11:38 PM
$CHE Selected for coverage by www.baorocapital.com. Target price = $850.
0 · Reply
macroaxis
macroaxis Jun. 15 at 11:12 PM
$CHE Put Open Interest Shifts for Chemed Corp This Week https://www.macroaxis.com/stock-options/CHE/Chemed-Corp?utm_source=dlvr.it&utm_medium=stocktwits
0 · Reply
NVDAMillionaire
NVDAMillionaire May. 14 at 6:21 AM
$CHE Really good write-up that perfectly summarizes CHE's present situation. So if you want to bring your CHE knowledge up to date or just discover CHE, this is required reading. https://everyticker.com/quote/CHE/analysis/chemed-s-asymmetric-turnaround-why-vitas-recovery-and-roto-rooter-resilience-make-this-dual-engine-story-compelling-nyse-che
0 · Reply
Latest News on CHE
Chemed boosts quarterly dividend to 70c from 60c per share

2026-08-06T16:00:44.000Z - 12 days ago

Chemed boosts quarterly dividend to 70c from 60c per share


Chemed Corporation Declares Quarterly Dividend of 70 Cents

Aug 6, 2026, 11:57 AM EDT - 12 days ago

Chemed Corporation Declares Quarterly Dividend of 70 Cents


Chemed price target raised to $590 from $500 at Oppenheimer

2026-07-31T12:00:53.000Z - 19 days ago

Chemed price target raised to $590 from $500 at Oppenheimer


Chemed price target raised to $548 from $436 at RBC Capital

2026-07-30T13:36:06.000Z - 19 days ago

Chemed price target raised to $548 from $436 at RBC Capital


Chemed Earnings Call Transcript: Q2 2026

Jul 29, 2026, 10:00 AM EDT - 20 days ago

Chemed Earnings Call Transcript: Q2 2026


Chemed Earnings release: Q2 2026

Jul 29, 2026, 10:00 AM EDT - 20 days ago

Chemed Earnings release: Q2 2026


Chemed Slides: Q2 2026

Jul 29, 2026, 10:00 AM EDT - 20 days ago

Chemed Slides: Q2 2026


Chemed Quarterly report: Q2 2026

Jul 29, 2026, 10:00 AM EDT - 20 days ago

Chemed Quarterly report: Q2 2026


Chemed reports Q2 adjusted EPS $6.06, consensus $5.60

2026-07-28T20:25:48.000Z - 21 days ago

Chemed reports Q2 adjusted EPS $6.06, consensus $5.60


Chemed Reports Second-Quarter 2026 Results

Jul 28, 2026, 4:15 PM EDT - 21 days ago

Chemed Reports Second-Quarter 2026 Results


Chemed price target raised to $510 from $450 at BofA

2026-07-09T10:00:16.000Z - 5 weeks ago

Chemed price target raised to $510 from $450 at BofA


Chemed price target raised to $436 from $422 at RBC Capital

2026-04-27T11:50:50.000Z - 4 months ago

Chemed price target raised to $436 from $422 at RBC Capital


Chemed Earnings Call Transcript: Q1 2026

Apr 24, 2026, 10:00 AM EDT - 4 months ago

Chemed Earnings Call Transcript: Q1 2026


Chemed Earnings release: Q1 2026

Apr 24, 2026, 10:00 AM EDT - 4 months ago

Chemed Earnings release: Q1 2026


Chemed Slides: Q1 2026

Apr 24, 2026, 10:00 AM EDT - 4 months ago

Chemed Slides: Q1 2026


Chemed Quarterly report: Q1 2026

Apr 24, 2026, 10:00 AM EDT - 4 months ago

Chemed Quarterly report: Q1 2026


Chemed reports Q1 adjusted EPS $5.65, consensus $5.30

2026-04-23T20:29:34.000Z - 4 months ago

Chemed reports Q1 adjusted EPS $5.65, consensus $5.30


Chemed Reports First-Quarter 2026 Results

Apr 23, 2026, 4:15 PM EDT - 4 months ago

Chemed Reports First-Quarter 2026 Results


Chemed Proxy statement: Proxy filing

Apr 9, 2026, 8:00 AM EDT - 4 months ago

Chemed Proxy statement: Proxy filing


Chemed Proxy statement: Proxy filing

Apr 6, 2026, 8:00 AM EDT - 4 months ago

Chemed Proxy statement: Proxy filing


Oppenheimer explores Chemed value in possible Roto-Rooter split

2026-03-31T14:26:41.000Z - 5 months ago

Oppenheimer explores Chemed value in possible Roto-Rooter split


Chemed price target lowered to $500 from $580 at Oppenheimer

2026-02-27T13:41:24.000Z - 6 months ago

Chemed price target lowered to $500 from $580 at Oppenheimer


Chemed downgraded to Neutral from Buy at BofA

2026-02-26T15:03:47.000Z - 6 months ago

Chemed downgraded to Neutral from Buy at BofA


Chemed price target lowered to $400 from $475 at Jefferies

2026-02-26T15:00:40.000Z - 6 months ago

Chemed price target lowered to $400 from $475 at Jefferies


Chemed Earnings Call Transcript: Q4 2025

Feb 26, 2026, 10:00 AM EST - 6 months ago

Chemed Earnings Call Transcript: Q4 2025


Chemed Annual report: Q4 2025

Feb 26, 2026, 10:00 AM EST - 6 months ago

Chemed Annual report: Q4 2025


Chemed Annual report: Q4 2025

Feb 26, 2026, 10:00 AM EST - 6 months ago

Chemed Annual report: Q4 2025


Chemed Earnings release: Q4 2025

Feb 26, 2026, 10:00 AM EST - 6 months ago

Chemed Earnings release: Q4 2025


Chemed Slides: Q4 2025

Feb 26, 2026, 10:00 AM EST - 6 months ago

Chemed Slides: Q4 2025


Chemed reports Q4 adjusted EPS $6.42, consensus $7.03

2026-02-25T22:03:36.000Z - 6 months ago

Chemed reports Q4 adjusted EPS $6.42, consensus $7.03


Chemed sees FY26 EPS $23.25-$24.25, consensus $25.41

2026-02-25T22:02:42.000Z - 6 months ago

Chemed sees FY26 EPS $23.25-$24.25, consensus $25.41


Chemed Reports Fourth-Quarter 2025 Results

Feb 25, 2026, 4:15 PM EST - 6 months ago

Chemed Reports Fourth-Quarter 2025 Results


Chemed board authorizes additional $300M for stock repurchases

2026-02-13T18:25:47.000Z - 6 months ago

Chemed board authorizes additional $300M for stock repurchases


Chemed Transcript: UBS Global Healthcare Conference 2025

Nov 11, 2025, 2:00 PM EST - 10 months ago

Chemed Transcript: UBS Global Healthcare Conference 2025


Chemed Corporation Declares Quarterly Dividend of 60 Cents

Nov 7, 2025, 11:28 AM EST - 10 months ago

Chemed Corporation Declares Quarterly Dividend of 60 Cents


Chemed Earnings Call Transcript: Q3 2025

Oct 29, 2025, 10:00 AM EDT - 10 months ago

Chemed Earnings Call Transcript: Q3 2025


Chemed Quarterly report: Q3 2025

Oct 29, 2025, 10:00 AM EDT - 10 months ago

Chemed Quarterly report: Q3 2025


Chemed Earnings release: Q3 2025

Oct 29, 2025, 10:00 AM EDT - 10 months ago

Chemed Earnings release: Q3 2025


Chemed Slides: Q3 2025

Oct 29, 2025, 10:00 AM EDT - 10 months ago

Chemed Slides: Q3 2025


Chemed Reports Third-Quarter 2025 Results

Oct 28, 2025, 4:15 PM EDT - 10 months ago

Chemed Reports Third-Quarter 2025 Results


Chemed Earnings Call Transcript: Q2 2025

Jul 30, 2025, 10:00 AM EDT - 1 year ago

Chemed Earnings Call Transcript: Q2 2025


Chemed Quarterly report: Q2 2025

Jul 30, 2025, 10:00 AM EDT - 1 year ago

Chemed Quarterly report: Q2 2025


Chemed Earnings release: Q2 2025

Jul 30, 2025, 10:00 AM EDT - 1 year ago

Chemed Earnings release: Q2 2025


Chemed Slides: Q2 2025

Jul 30, 2025, 10:00 AM EDT - 1 year ago

Chemed Slides: Q2 2025


Chemed To Report Second-Quarter 2025 Earnings July 29, 2025

Jun 27, 2025, 4:15 PM EDT - 1 year ago

Chemed To Report Second-Quarter 2025 Earnings July 29, 2025


Chemed Transcript: BofA Securities 2025 Healthcare Conference

May 13, 2025, 6:40 PM EDT - 1 year ago

Chemed Transcript: BofA Securities 2025 Healthcare Conference


Chemed Slides: FY 2025

May 13, 2025, 6:40 PM EDT - 1 year ago

Chemed Slides: FY 2025


Chemed Earnings Call Transcript: Q1 2025

Apr 24, 2025, 10:00 AM EDT - 1 year ago

Chemed Earnings Call Transcript: Q1 2025


Chemed Quarterly report: Q1 2025

Apr 24, 2025, 10:00 AM EDT - 1 year ago

Chemed Quarterly report: Q1 2025


Chemed Earnings release: Q1 2025

Apr 24, 2025, 10:00 AM EDT - 1 year ago

Chemed Earnings release: Q1 2025


Chemed Slides: Q1 2025

Apr 24, 2025, 10:00 AM EDT - 1 year ago

Chemed Slides: Q1 2025


Chemed Reports First-Quarter 2025 Results

Apr 23, 2025, 4:15 PM EDT - 1 year ago

Chemed Reports First-Quarter 2025 Results


Chemed Proxy statement: Proxy Filing

Apr 7, 2025, 8:00 AM EDT - 1 year ago

Chemed Proxy statement: Proxy Filing


Chemed Earnings Call Transcript: Q4 2024

Feb 27, 2025, 10:00 AM EST - 1 year ago

Chemed Earnings Call Transcript: Q4 2024


Chemed Annual report: Q4 2024

Feb 27, 2025, 10:00 AM EST - 1 year ago

Chemed Annual report: Q4 2024


Chemed Earnings release: Q4 2024

Feb 27, 2025, 10:00 AM EST - 1 year ago

Chemed Earnings release: Q4 2024


Chemed Slides: Q4 2024

Feb 27, 2025, 10:00 AM EST - 1 year ago

Chemed Slides: Q4 2024


Chemed Reports Fourth-Quarter 2024 Results

Feb 26, 2025, 4:15 PM EST - 1 year ago

Chemed Reports Fourth-Quarter 2024 Results


Chemed Corporation Declares Quarterly Dividend of 50 Cents

Feb 14, 2025, 1:30 PM EST - 1 year ago

Chemed Corporation Declares Quarterly Dividend of 50 Cents


Chemed Transcript: Bank of America Home Care Conference

Dec 10, 2024, 1:20 PM EST - 1 year ago

Chemed Transcript: Bank of America Home Care Conference


Chemed Transcript: UBS Global Healthcare Conference 2024

Nov 12, 2024, 2:45 PM EST - 1 year ago

Chemed Transcript: UBS Global Healthcare Conference 2024


Chemed Earnings Call Transcript: Q3 2024

Oct 30, 2024, 10:00 AM EDT - 1 year ago

Chemed Earnings Call Transcript: Q3 2024


Chemed Quarterly report: Q3 2024

Oct 30, 2024, 10:00 AM EDT - 1 year ago

Chemed Quarterly report: Q3 2024


Chemed Earnings release: Q3 2024

Oct 30, 2024, 10:00 AM EDT - 1 year ago

Chemed Earnings release: Q3 2024


Chemed Slides: Q3 2024

Oct 30, 2024, 10:00 AM EDT - 1 year ago

Chemed Slides: Q3 2024


Chemed Reports Third-Quarter 2024 Results

Oct 29, 2024, 4:15 PM EDT - 1 year ago

Chemed Reports Third-Quarter 2024 Results


Final Trades: Exxon, Chemed, Las Vegas Sands and the IEO

Oct 1, 2024, 1:23 PM EDT - 2 years ago

Final Trades: Exxon, Chemed, Las Vegas Sands and the IEO

LVS XOM IEO


Chemed Earnings Call Transcript: Q2 2024

Jul 25, 2024, 10:00 AM EDT - 2 years ago

Chemed Earnings Call Transcript: Q2 2024


Chemed Quarterly report: Q2 2024

Jul 25, 2024, 10:00 AM EDT - 2 years ago

Chemed Quarterly report: Q2 2024


Chemed Earnings release: Q2 2024

Jul 25, 2024, 10:00 AM EDT - 2 years ago

Chemed Earnings release: Q2 2024


Chemed Slides: Q2 2024

Jul 25, 2024, 10:00 AM EDT - 2 years ago

Chemed Slides: Q2 2024


Chemed Reports Second-Quarter 2024 Results

Jul 24, 2024, 4:15 PM EDT - 2 years ago

Chemed Reports Second-Quarter 2024 Results


Chemed Transcript: BofA Securities 2024 Health Care Conference

May 14, 2024, 4:40 PM EDT - 2 years ago

Chemed Transcript: BofA Securities 2024 Health Care Conference


Chemed Earnings Call Transcript: Q1 2024

Apr 25, 2024, 10:00 AM EDT - 2 years ago

Chemed Earnings Call Transcript: Q1 2024


Chemed Quarterly report: Q1 2024

Apr 25, 2024, 10:00 AM EDT - 2 years ago

Chemed Quarterly report: Q1 2024


Chemed Earnings release: Q1 2024

Apr 25, 2024, 10:00 AM EDT - 2 years ago

Chemed Earnings release: Q1 2024


Chemed Slides: Q1 2024

Apr 25, 2024, 10:00 AM EDT - 2 years ago

Chemed Slides: Q1 2024


Chemed Reports First-Quarter 2024 Results

Apr 24, 2024, 4:15 PM EDT - 2 years ago

Chemed Reports First-Quarter 2024 Results


STRelativeStrength
STRelativeStrength Aug. 10 at 2:36 PM
$CHE undiscovered breakout with 299 watchers
1 · Reply
MichaelKost
MichaelKost Aug. 8 at 6:41 PM
$CHE I'll give it another look tomorrow
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Jul. 28 at 8:36 PM
$CHE Q2 '26 Earnings Results & Recap • Reported GAAP EPS of $5.14 up 42.78% YoY • Reported revenue of $673.25M up 8.80% YoY • Chemed Corporation raised its full-year 2026 earnings per diluted share guidance to a range of $25.00 to $25.75, representing a 17.8% increase from 2025 adjusted earnings per diluted share.
0 · Reply
onlythebestcompanies
onlythebestcompanies Jul. 21 at 12:54 PM
$CHE $600 soon.
0 · Reply
onlythebestcompanies
onlythebestcompanies Jul. 17 at 12:52 PM
$CHE $600 soon.
0 · Reply
IN0V8
IN0V8 Jul. 9 at 5:32 PM
$CHE Opportunity BofA Global Research raises price objective to $510.00 from $450.00
0 · Reply
onlythebestcompanies
onlythebestcompanies Jul. 6 at 7:11 AM
$CHE $600 soon.
0 · Reply
leochoi834
leochoi834 Jul. 3 at 11:38 PM
$CHE Selected for coverage by www.baorocapital.com. Target price = $850.
0 · Reply
macroaxis
macroaxis Jun. 15 at 11:12 PM
$CHE Put Open Interest Shifts for Chemed Corp This Week https://www.macroaxis.com/stock-options/CHE/Chemed-Corp?utm_source=dlvr.it&utm_medium=stocktwits
0 · Reply
NVDAMillionaire
NVDAMillionaire May. 14 at 6:21 AM
$CHE Really good write-up that perfectly summarizes CHE's present situation. So if you want to bring your CHE knowledge up to date or just discover CHE, this is required reading. https://everyticker.com/quote/CHE/analysis/chemed-s-asymmetric-turnaround-why-vitas-recovery-and-roto-rooter-resilience-make-this-dual-engine-story-compelling-nyse-che
0 · Reply
Estimize
Estimize Apr. 30 at 8:03 PM
Wall St is expecting 5.63 EPS for $CHE Q2 [Reporting 07/29 AMC] http://www.estimize.com/intro/che?chart=historical&metric_name=eps&utm_cont
0 · Reply
PenkeInvesting
PenkeInvesting Apr. 30 at 6:32 PM
Fundamental analysis of $CHE (CHEMED CORP) based on financial data and reported results. #CHE #CHEMED
0 · Reply
OpenOutcrier
OpenOutcrier Apr. 24 at 12:33 PM
$CHE (+8.4% pre) Chemed (CHE) Beats Q1 Earnings and Revenue Estimates https://ooc.bz/l/99915
0 · Reply
topstockalerts
topstockalerts Apr. 23 at 10:05 PM
After Hours Top Gainers PT2 $HKPD $TIVC $CISS $PDFS $CHE
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Apr. 23 at 8:40 PM
$CHE Q1 '26 Earnings Results & Recap • Reported GAAP EPS of $4.85 down -1.22% YoY • Reported revenue of $657.51M up 1.63% YoY • Chemed raised full-year 2026 adjusted diluted EPS guidance to $24.00-$24.75, reflecting improved VITAS performance. However, Roto-Rooter's adjusted EBITDA margin guidance was lowered to 21.5%-22.5% due to elevated marketing costs.
0 · Reply
Estimize
Estimize Apr. 20 at 10:01 AM
Wall St is expecting 5.30 EPS for $CHE Q1 [Reporting 04/23 AMC] http://www.estimize.com/intro/che?chart=historical&metric_name=eps&utm_cont
0 · Reply
ZacksResearch
ZacksResearch Feb. 27 at 6:36 PM
$CHE just got crushed — and this isn’t just a “small miss.” ⚠️ Shares slipped 15% after Q4 earnings and revenue both missed estimates, margins contracted, and the 2026 EPS outlook came in below consensus. That’s a triple hit to confidence. When growth stalls and guidance disappoints at the same time, the market reprices fast. See the full breakdown and what this means for the stock 👉 https://www.zacks.com/stock/news/2877001/che-stock-falls-post-q4-earnings-revenue-miss-margins-crash?cid=sm-stocktwits-2-2877001-teaser-35586&ADID=SYND_STOCKTWITS_TWEET_2_2877001_TEASER_35586
0 · Reply
ZacksResearch
ZacksResearch Feb. 27 at 5:36 PM
$CHE drops 15% post-earnings — what’s the downturn about? 📉 Chemed's Q4 adjusted EPS of $6.42 missed the Zacks Consensus Estimate by 8.55%, with revenues also falling short by 2.55%. VITAS saw revenue growth, while Roto-Rooter faced a decline, alongside margin contraction. Full insights here 👉 https://www.zacks.com/stock/news/2877001/che-stock-falls-post-q4-earnings-revenue-miss-margins-crash?cid=sm-stocktwits-2-2877001-body-35587&ADID=SYND_STOCKTWITS_TWEET_2_2877001_BODY_35587
0 · Reply
hunanddone
hunanddone Feb. 26 at 2:25 PM
$CHE I know little to nothing about this stock and company. Apparently none of miss was baked in?? It was at 24 x trailing before this slaughter going sub 20. I would think after a substantial short attack cuz noone will stand up on the bid, it will deadcat for a nice trade. Gonna be watching it
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Feb. 25 at 9:45 PM
$CHE Q4 '25 Earnings Results & Recap • Reported GAAP EPS of $5.48 down -9.87% YoY • Reported revenue of $639.34M down -0.10% YoY • Chemed estimates full-year 2026 adjusted diluted EPS between $23.25 and $24.25, with VITAS revenue projected to increase 5.5% to 6.5% and Roto-Rooter revenue growth of 3.0% to 3.5%.
0 · Reply